Psi Advisors, LLC Astrazeneca PLC Transaction History
Psi Advisors, LLC
- $338 Million
- Q3 2024
A detailed history of Psi Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Psi Advisors, LLC holds 137 shares of AZN stock, worth $9,784. This represents 0.0% of its overall portfolio holdings.
Number of Shares
137
Previous 137
-0.0%
Holding current value
$9,784
Previous $10,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AZN
# of Institutions
1,345Shares Held
492MCall Options Held
4.99MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.64 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.04 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$2.9 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.62 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.26 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $221B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...